We are investing to support the Reef to recover and adapt to a changing environment. We are also rehabilitating Reef habitats to restore previous damage and build resilience. This helps to minimise ...

No matter the format or the distance of the walk, a good pair of walking shoes can make the difference between a pleasant stroll and one that ends in an achy lower back, sweaty feet, and blisters ...

Here’s how it works. We all know how important it is to wear a good pair of running shoes to avoid injury, feel comfortable, and perform at our best. But with so many options out there ...

Wednesday, Teva revealed booming third-quarter sales for its generics and biosimilars. In the U.S., revenue from the knockoffs came in at $1.1 billion, which was a 30% increase year over year, or ...

On October 31, 2024, the European Commission issued a fine of €462.6 million to Teva Pharmaceuticals, citing abuse of its market dominance by delaying competition for Copaxone, a leading multiple ...

Revenue and your browsing history impact the experiences featured on this page, learn more. Product categories and sub-categories are ranked based on revenue made by Tripadvisor, popularity of tours ...

To do that, Teva conducted a "disparagement campaign" against Synthon, the only other company with an authorised drug in Europe containing glatiramer acetate, the Commission said in a statement.

The wrong pair of dress shoes can be stiff and painful. The right dress shoes, on the other hand, mold to your feet and feel great all day. After speaking to footwear experts and testing multiple ...

Teva Hit With €463 Million EU Fine for Talking Down Rivals EU says Israeli firm thwarted competition for MS drug Teva vows to appeal decision, says it is ‘deeply dissapointed’ ...

Some two years after the European Commission accused Teva of meddling with the competition for its former multiple sclerosis blockbuster Copaxone, the other shoe has finally dropped. The European ...

Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. The European Commission has fined Teva, the world’s largest generic drugmaker, €462.6mn for hindering ...